<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for South Wigston Health Ctr.</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from 1 April 2021 to 1 August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where South Wigston Health Ctr. is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=1306010V0&amp;denomIds=13.6.1&amp;selectedTab=summary">Tretinoin</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Topical preparations for acne</td>
      <td>40</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>59.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=1306010V0AAALAL&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Tretinoin 0.01% gel : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=1302010Z0&amp;denomIds=13.2.1&amp;selectedTab=summary">Chlohexidine gluconate (Emollient)</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Emollients</td>
      <td>162</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>13.59</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=1302010Z0BBAAAA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Eczmol 1% cream : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0401010AC&amp;denomIds=4.1.1&amp;selectedTab=summary">Sodium oxybate</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Hypnotics</td>
      <td>412</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>10.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0401010ACBBAAAA&amp;denomIds=4.1.1&amp;selectedTab=summary" target="_blank">Xyrem 500mg/ml oral solution : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0407020H0&amp;denomIds=4.7.2&amp;selectedTab=summary">Dipipanone hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Opioid analgesics</td>
      <td>1291</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>9.78</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0407020H0AAABAB&amp;denomIds=4.7.2&amp;selectedTab=summary" target="_blank">Dipipanone 10mg / Cyclizine 30mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=1001040K0&amp;denomIds=10.1.4&amp;selectedTab=summary">Probenecid</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Gout and cytotoxic induced hyperiuicaemia</td>
      <td>311</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>7.70</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=1001040K0AAAAAA&amp;denomIds=10.1.4&amp;selectedTab=summary" target="_blank">Probenecid 500mg tablets : 2</a></div></td></tr></tbody></table>

        <h2>Prescribing where South Wigston Health Ctr. is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0&amp;denomIds=1.5.1&amp;selectedTab=summary">Mesalazine (Systemic)</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>47</td>
      <td>Aminosalicylates</td>
      <td>132</td>
      <td>0.36</td>
      <td>0.64</td>
      <td>0.15</td>
      <td>-1.94</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0AAAJAJ&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 1g suppositories : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BIABAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 400mg MR gastro-resistant tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BDAHAU&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Salofalk 1.5g gastro-resistant modified-release gran sachets : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BCACAI&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 500mg modified-release tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BBAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Asacol 400mg MR gastro-resistant tablets : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BCAEAN&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release granules sachets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0AAAAAA&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Mesalazine 400mg gastro-resistant tablets : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BCAGAY&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Pentasa 1g modified-release tablets : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0105010B0BIAAAS&amp;denomIds=1.5.1&amp;selectedTab=summary" target="_blank">Octasa 800mg MR gastro-resistant tablets : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0205020M0&amp;denomIds=2.5.2&amp;selectedTab=summary">Moxonidine</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Centrally-acting antihypertensive drugs</td>
      <td>2</td>
      <td>0.00</td>
      <td>0.64</td>
      <td>0.34</td>
      <td>-1.92</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0&amp;denomIds=1.3.5&amp;selectedTab=summary">Omeprazole</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>596</td>
      <td>Proton pump inhibitors</td>
      <td>3090</td>
      <td>0.19</td>
      <td>0.50</td>
      <td>0.16</td>
      <td>-1.89</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AAAAAA&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 20mg gastro-resistant capsules : 443</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AAAEAE&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 40mg gastro-resistant capsules : 46</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AAAFAF&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 10mg gastro-resistant capsules : 61</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AAANAN&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 20mg dispersible gastro-resistant tablets : 13</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AABDBD&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 20mg gastro-resistant tablets : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AAAPAP&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 40mg dispersible gastro-resistant tablets : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0103050P0AABUBU&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Omeprazole 10mg/5ml oral suspension sugar free : 24</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0301040W0&amp;denomIds=3.1.4&amp;selectedTab=summary">Umeclidinium bromide/vilanterol</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Compound bronchodilator preparations</td>
      <td>63</td>
      <td>0.00</td>
      <td>0.50</td>
      <td>0.31</td>
      <td>-1.63</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0&amp;denomIds=3.2&amp;selectedTab=summary">Fluticasone propionate (Inhalation)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>63</td>
      <td>Corticosteroids (respiratory)</td>
      <td>1214</td>
      <td>0.05</td>
      <td>0.18</td>
      <td>0.08</td>
      <td>-1.56</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BBBBBH&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Flixotide 50micrograms/dose Evohaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BCABAY&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Seretide 250 Accuhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BFABBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Sirdupla 25micrograms/dose / 250micrograms/dose inhaler : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BCAEBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Seretide 125 Evohaler : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BCACAZ&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Seretide 500 Accuhaler : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0AABCBC&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fluticasone 250micrograms/dose inhaler CFC free : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0AABFBF&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Fluticasone 125mcg/dose / Salmeterol 25mcg/dose inh CFC free : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BCAFBG&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Seretide 250 Evohaler : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C82079&amp;numIds=0302000N0BCADBE&amp;denomIds=3.2&amp;selectedTab=summary" target="_blank">Seretide 50 Evohaler : 25</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>